This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
5 Stocks With Rising P/E to Snap Up for Spectacular Gains
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
Zacks.com featured highlights include: Murphy USA, Owens Corning, Commercial Metals, Whirlpool and Select Medical Holdings
by Zacks Equity Research
Zacks.com featured highlights include: Murphy USA, Owens Corning, Commercial Metals, Whirlpool and Select Medical Holdings
The 5 Best Relative Price Strength Stocks to Buy Right Now
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Select Medical's (SEM) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Select Medical's (SEM) second-quarter earnings performance benefits from lower expenses.
Select Medical (SEM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 733.33% and 1.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Select Medical Stock
by Zacks Equity Research
Select Medical (SEM) is well poised to benefit from improved revenues and strong cash flows.
Select Medical (SEM) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Select Medical (SEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks.com
Depressed revenues and elevated expenses make HCA Healthcare (HCA) an unattractive bet.
Select Medical (SEM) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 12.12% and 2.12%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact
by Sapna Bagaria
Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.
Zacks.com featured highlights include: Avid Technology, Navient, Sykes Enterprises, Lake Gold and Select Medical
by Zacks Equity Research
Zacks.com featured highlights include: Avid Technology, Navient, Sykes Enterprises, Lake Gold and Select Medical
5 Stocks With High Earnings Yield to Enhance Your Portfolio
by Zacks Equity Research
Beat the coronavirus blues by investing in these high earnings yield stocks.
SEM vs. UNH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SEM vs. UNH: Which Stock Is the Better Value Option?
6 Valuable Price-to-Book Stocks to Buy as Recession Lurks
by Kinjel Shah
Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical Revokes Full-Year View Amid Coronavirus Blues
by Zacks Equity Research
Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.
5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis
by Sumit Singh
Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.
SEM vs. HUM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SEM vs. HUM: Which Stock Is the Better Value Option?
Anthem (ANTM) Issues Policies for Safe Coronavirus Testing
by Zacks Equity Research
Anthem (ANTM) issues updates to ease care provider protocols regarding COVID-19 testing
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical (SEM) Down 55.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Select Medical (SEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020
by Srijita Guha
HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.
Will Select Medical Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Select Medical.